| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 11 |
| 1 | DOCETAXEL ANHYDROUS | 11 |
| 2 | PACLITAXEL | 11 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 11 |
| 4 | TRASTUZUMAB | 11 |
| 5 | CAPECITABINE | 9 |
| 6 | LAPATINIB | 8 |
| 7 | CARBOPLATIN | 7 |
| 8 | METHOTREXATE | 7 |
| 9 | METHOTREXATE SODIUM | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VINORELBINE | 6 | 0.0009 |
| 1 | TALQUETAMAB-TGVS | 1 | 0.0007 |
| 2 | DICHLORPHENAMIDE | 1 | 0.0006 |
| 3 | LAPATINIB | 8 | 0.0005 |
| 4 | RITLECITINIB | 1 | 0.0005 |
| 5 | BRODALUMAB | 1 | 0.0005 |
| 6 | ARSENIC TRIOXIDE | 1 | 0.0004 |
| 7 | DACARBAZINE | 3 | 0.0004 |
| 8 | ESLICARBAZEPINE ACETATE | 1 | 0.0003 |
| 9 | BLEOMYCIN SULFATE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 11 | 0.0001 |
| 2 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Anti-anginal [EPC] | 1 | 0.0001 |
| 4 | Microtubule Inhibitor [EPC] | 14 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 6 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 7 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Estrogen Receptor Antagonist [EPC] | 2 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 12 | 0.0000 |